CareNet
VC Fund
Tokyo, Japan
CareNet is a marketing company providing various solutions to pharma companies through the management of media specialized in medical/pharmaceutical education for HCPs. For more than 20 years and since its foundation in 1996, CareNet has continually provided places for exchanging therapeutic information, as well as valuable solutions to HCPsand pharmaceutical companies from the position of the No. 1 media in clinical medical education.
- Total investments:
- 3
- Last investment:
- Lead investor:
- 0%
Last updated:
For AI agents: llms.txt
Industries CareNet invests in
Stages CareNet invests in
Countries CareNet invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
3 more contacts available
Investment Focus
Industry
- Life Science 2 (67%)
- Biotechnology 2 (67%)
- Health Care 1 (33%)
- Therapeutics 1 (33%)
Stage
- Series A 1 (33%)
- Series B 1 (33%)
- Series C 1 (33%)
Country
- Japan 1 (33%)
- United States 1 (33%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Katsuhiro Fujii
President and COO
|
President and COO | Total investments: 0 | Find email | |
|
Motoyasu Ohno
Chairman and CEO
|
Chairman and CEO | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
DiscGenics
|
Clinical stage biotechnology company developing cell-based regenerative therapies that alleviate pain and restore function in patients with degenerative diseases of the spine. | $50M / Series C / Aug 25, 2020 | |
Modalis Therapeutics
|
Modalis Therapeutics Corporation is an biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary technologies on CRISPR and protein engineering platforms. The company has a strong foundation on intellectual property licensed from the University of Tokyo. | $25M / Series B / Apr 10, 2019 | |
|
Modalis Therapeutics
|
Modalis Therapeutics Corporation is an biotech company focusing on developing transformative therapeutics for unmet medical needs using its proprietary technologies on CRISPR and protein engineering platforms. The company has a strong foundation on intellectual property licensed from the University of Tokyo. | $73.7M / Series A / Dec 20, 2017 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Featured in Investor Lists
Recommended lists
FAQ
What does CareNet invest in?
CareNet invests primarily in Life Science, Biotechnology and Health Care startups, most often at Series A and Series B stage. Most of the 3 investments tracked by Shizune back companies in Japan. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact CareNet?
Public channels for CareNet include the website linked on this profile and Facebook. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CareNet?
The team at CareNet includes Katsuhiro Fujii (President and COO) and Motoyasu Ohno (Chairman and CEO). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
